Home » Stocks » MDVL

MedAvail, Inc (MDVL)

Stock Price: $14.16 USD 0.31 (2.24%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Market Cap 451.92M
Revenue (ttm) 1.48M
Net Income (ttm) -3.64M
Shares Out 987,229
EPS (ttm) -4.08
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $14.16
Previous Close $13.85
Change ($) 0.31
Change (%) 2.24%
Day's Open 13.82
Day's Range 13.82 - 14.48
Day's Volume 29,333
52-Week Range 0.85 - 18.04

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Business Wire - 1 week ago

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”), a technology-enabled retail pharmacy company driving best in class medication adherence by...

Business Wire - 2 weeks ago

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled retail pharmacy company driving best in class medication adherence by ...

Business Wire - 2 months ago

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)--MedAvail Holdings, Inc. (“MedAvail”), a leading technology-enabled pharmacy organization that embeds automated pharmacy services directly into ...

Business Wire - 2 months ago

MISSISSAUGA, Ontario & CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--MedAvail, Inc. (“MedAvail”), a leading technology-enabled pharmacy organization that embeds pharmacy services directly into clinics ...

PRNewsWire - 2 months ago

CEDAR KNOLLS, N.J., Nov. 12, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) As previously announced, on June 30, 2020, MYOS RENS Technology, Inc., a Ne...

PRNewsWire - 2 months ago

CEDAR KNOLLS, N.J., Nov. 6, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary ...

PRNewsWire - 6 months ago

NEW YORK, July 7, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MYOS RENS Technology Inc. ("MY...

PRNewsWire - 6 months ago

CEDAR KNOLLS, N.J., July 7, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a...

PRNewsWire - 6 months ago

NEW YORK, July 2, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between MYOS RENS Technology Inc. (NASDAQ: MYOS) and MedAvail, I...

Newsfile Corp - 6 months ago

New York, New York--(Newsfile Corp. - July 2, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased MYOS RENS Technology Inc. (NASD...

Benzinga - 6 months ago

Shares of nutrition company MYOS Corporation (NASDAQ: MYOS) were more than doubling Wednesday.

PRNewsWire - 6 months ago

CEDAR KNOLLS, N.J. and MISSISSAUGA, Ontario, June 30, 2020 /PRNewswire/ -- MYOS RENS Technology, Inc. ("MYOS") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a pr...

PRNewsWire - 8 months ago

CEDAR KNOLLS, N.J., May 14, 2020 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition th...

Seeking Alpha - 8 months ago

MYOS RENS Technology's (MYOS) CEO Joseph Mannello on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 9 months ago

MYOS RENS Technology Inc (MYOS) CEO Joseph Mannello on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

MYOS RENS Technology Inc (MYOS) CEO Joseph Mannello on Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

MYOS RENS Technology Inc. (MYOS) CEO Joseph Mannello on Q1 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

MYOS RENS Technology Inc. (MYOS) CEO Joseph Mannello on Q4 2018 Results - Earnings Call Transcript

About MDVL

MedAvail Holdings operates as a technology enabled pharmacy company that embeds automated pharmacy services directly into clinics and other points of care through its proprietary technology. The company provides turnkey services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations. It also operates SpotRx, a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery. MedAvail Holdings, Inc. is based in Mississauga, Ca... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
CEO
Joseph Mannello
Employees
137
Stock Exchange
NASDAQ
Ticker Symbol
MDVL
Full Company Profile

Financial Performance

In 2019, MedAvail's revenue was $1.03 million, an increase of 186.67% compared to the previous year's $360,000. Losses were -$4.26 million, 32.1% more than in 2018.

Financial Statements